Stockscreener 앱 받기
19.40
0.56%
-0.11
시간 외 거래:
19.40
Theravance Biopharma Inc 주식(TBPH)의 최신 뉴스
Baader Bank Aktiengesellschaft Invests $781,000 in Theravance Biopharma, Inc. $TBPH - MarketBeat
Theravance Biopharma Inc (NASDAQ:TBPH) Shows Strong Technical and Fundamental Momentum - ChartMill
Is Theravance Biopharma Inc. stock showing strong momentumJuly 2025 Macro Moves & Weekly Setup with ROI Potential - mfd.ru
Theravance Biopharma, Inc. (NASDAQ:TBPH) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
Precision Trading with Theravance Biopharma Inc. (TBPH) Risk Zones - Stock Traders Daily
RSI Check: Can Theravance Biopharma Inc sustain its profitabilityEarnings Risk Summary & Weekly High Return Stock Forecasts - baoquankhu1.vn
A Glimpse Into The Expert Outlook On Theravance Biopharma Through 4 Analysts - Benzinga
Theravance Biopharma's (TBPH) "Buy" Rating Reaffirmed at BTIG Research - MarketBeat
TBPH Stock: BTIG Reiterates 'Buy' Rating at $40 Target Price | T - GuruFocus
While shareholders of Theravance Biopharma (NASDAQ:TBPH) are in the black over 1 year, those who bought a week ago aren't so fortunate - simplywall.st
Is the Options Market Predicting a Spike in Theravance Biopharma Stock? - sharewise.com
Theravance Biopharma (NASDAQ:TBPH) Share Price Passes Above Fifty Day Moving AverageHere's What Happened - MarketBeat
Technical Reactions to TBPH Trends in Macro Strategies - Stock Traders Daily
Theravance Biopharma stock hits 52-week high at $21.01 By Investing.com - au.investing.com
Why Theravance Biopharma (TBPH) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Profit Review: Is Theravance Biopharma Inc affected by consumer sentimentSell Signal & Safe Entry Zone Identification - baoquankhu1.vn
Theravance Biopharma stock hits 52-week high at $21.01 - Investing.com
Theravance Biopharma (NASDAQ:TBPH) Reaches New 1-Year HighHere's What Happened - MarketBeat
Neurogenic Orthostatic Hypotension (nOH) Global Clinical Trials Market Review 2025: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status - GlobeNewswire Inc.
Why Theravance Biopharma (TBPH) is a Top Growth Stock for the Long-Term - sharewise.com
Theravance Biopharma, Inc. (NASDAQ:TBPH) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat
Theravance Biopharma stock hits 52-week high at 20.69 USD By Investing.com - Investing.com Nigeria
Theravance Biopharma stock hits 52-week high at 20.69 USD - Investing.com
Trading the Move, Not the Narrative: (TBPH) Edition - Stock Traders Daily
Theravance Biopharma (NASDAQ:TBPH) Sets New 12-Month HighWhat's Next? - MarketBeat
Theravance Biopharma CEO earns 2026 Honorable Mentor title - Traders Union
Theravance Biopharma, Inc. Announces Upcoming Phase 3 Data for Ampreloxetine - TradingView — Track All Markets
Theravance Biopharma, Inc. (TBPH) Stock Analysis: Unpacking A 40% Potential Upside - DirectorsTalk Interviews
What valuation ratios show for Theravance Biopharma Inc. (0TB) stockJuly 2025 Technicals & Reliable Entry Point Alerts - Улправда
Chart Watch: What valuation ratios show for Theravance Biopharma Inc. (0TB) stockWeekly Trend Recap & Smart Investment Allocation Tips - Улправда
Will Theravance Biopharma Inc. stock deliver better than expected guidanceMarket Activity Summary & Verified Momentum Stock Ideas - Улправда
Published on: 2026-01-08 18:37:29 - Улправда
mF International, Theravance Biopharma And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Theravance Biopharma (NASDAQ:TBPH) Share Price Crosses Above Fifty Day Moving AverageWhat's Next? - MarketBeat
Theravance Biopharma (NASDAQ:TBPH) Share Price Crosses Above Fifty Day Moving Average – What’s Next? - Defense World
(TBPH) Volatility Zones as Tactical Triggers - Stock Traders Daily
Theravance Biopharma (NASDAQ:TBPH) Lowered to Buy Rating by Wall Street Zen - MarketBeat
Portfolio Update: Why Theravance Biopharma Inc 0TB stock stays resilient2025 Short Interest & Daily Entry Point Alerts - moha.gov.vn
Can Theravance Biopharma's Ampreloxetine Fill The Gap In MSA-Related NOH Therapy? - RTTNews
Market Overview: Is Theravance Biopharma Inc stock trading near support levels2025 Macro Impact & Weekly Return Optimization Plans - Bộ Nội Vụ
What drives Theravance Biopharma Inc stock priceMarket Insider Reports & Build Your Portfolio With Our Free Stock Scanner - earlytimes.in
Inspire Investing LLC Purchases New Position in Theravance Biopharma, Inc. $TBPH - MarketBeat
Here's Why Theravance Biopharma (TBPH) is a Strong Growth Stock - sharewise.com
(TBPH) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Wall Street Analysts Believe Theravance Bio (TBPH) Could Rally 42.15%: Here's is How to Trade - Finviz
1.24%
0.19%
자본화:
|
볼륨(24시간):